Results 281 to 290 of about 370,229 (352)

Tuberculosis in patients with systemic lupus erythematosus. [PDF]

Front Immunol
Ongarj J, Intapiboon P, Tanner R, Pinpathomrat N.   +3 more
europepmc   +1 more source

Effect of Systemic Immunomodulators on Incidence of Alopecia Areata: A Retrospective Cohort Study

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Alopecia areata (AA) is a chronic autoimmune hair loss disorder. Patients with primary autoimmune diseases commonly use systemic immunomodulators to manage disease and have an increased risk of developing AA. Systemic immunomodulators have diverse immunologic effects, but their impact on AA risk is not well understood. Objectives We
Angela Rose Liu, Nada Hentati, Bethany R. Rohr   +2 more
wiley   +1 more source

Racial differences in medication beliefs and adherence barriers among patients with systemic lupus erythematosus. [PDF]

Lupus
Rangaswamy S, Eudy AM, Clowse MEB, Rogers J, Sadun RE, Criscione-Schreiber LG, Doss J, Maheswaranathan M, Harris N, Burshell DR, Sun K.   +10 more
europepmc   +1 more source

Pulmonary Hypertension in Systemic Lupus Erythematosus: Current Evidence and Future Directions. [PDF]

Cureus
Santacruz JC, Mantilla MJ, Pulido S, Agudelo C, Naranjo JA, Vergara OV, Londono J.   +6 more
europepmc   +1 more source

Juvenile-onset Systemic Lupus Erythematosus: Recent Advances in Pathogenesis and Treatment. [PDF]

Curr Rheumatol Rep
Natoli V, Charras A, Smith EM, Hedrich CM.   +3 more
europepmc   +1 more source

Specific cutaneous histologic and immunologic features in a case of early lupus erythematosus scarring alopecia

, 2013
Ana María Abreu Vélez, A. Deo Klein, Michael S. Howard   +2 more
openalex   +1 more source

Never say never

Journal of Hospital Medicine, EarlyView.
Gurpreet Dhaliwal, Jagmeet Dhingra, Tom Fraser, Leal Herlitz, James Pile   +4 more
wiley   +1 more source

Clinical Features and Therapeutic Outcomes in Pyoderma Gangrenosum: A Prospective Cohort Study

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis highly associated with systemic comorbidities. Accurate diagnosis and treatment remain challenging due to its rarity and clinical mimickers. Objectives To evaluate demographic, clinical features and treatment outcomes in patients referred with suspected PG at a tertiary ...
David Croitoru, Nesrine Brahimi, Haleh Zabihi, Cathryn Sibbald, Kyle Seigel, Delaram Shojaei, Eric McMullen, Afsaneh Alavi, Lily Archaempong, Aaron M. Drucker, Adam Weizman, Kenneth Croitoru, Robert Inman, Vincent Piguet   +13 more
wiley   +1 more source

The role of DNASE1L3 in systemic lupus erythematosus: from pathogenesis to clinical implications. [PDF]

Clin Exp Med
Liu X, Yu Y, Cai S, Dong L.
europepmc   +1 more source

Intraindividual cognitive function course over time in patients with systemic lupus erythematosus. [PDF]

RMD Open
Tayer-Shifman OE, Su J, Bingham K, Kakvan M, Tartaglia MC, Ruttan L, Marzouk S, Wither J, Choi MY, Bonilla D, Appenzeller S, Beaton D, Katz P, Green R, Gladman DD, Touma Z.   +15 more
europepmc   +1 more source